Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.56
+2.29 (1.12%)
AAPL  274.19
+8.01 (3.01%)
AMD  209.58
+12.98 (6.60%)
BAC  49.77
-1.30 (-2.54%)
GOOG  309.12
-2.57 (-0.82%)
META  635.73
-1.52 (-0.24%)
MSFT  386.93
+2.45 (0.64%)
NVDA  192.45
+0.90 (0.47%)
ORCL  145.47
+4.16 (2.94%)
TSLA  406.48
+6.65 (1.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.